The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II trial of combination pembrolizumab, olaparib, and temozolomide for patients with recurrent glioma.
 
Lauren Schaff
Consulting or Advisory Role - BTG
Research Funding - BTG
 
John Fortunato
No Relationships to Disclose
 
Christian Grommes
Honoraria - Scripps Health
Consulting or Advisory Role - BTG; Kite/Gilead; Ono Pharmaceutical
Other Relationship - Bayer; Bristol-Myers Squibb; Celgene; Pharmacyclics
 
Igor T. Gavrilovic
No Relationships to Disclose
 
Andrew Lin
Stock and Other Ownership Interests - Abbott Laboratories; Amedisys; Atea; Dexcom; Novo Nordisk; Tandem Diabetes Care
Research Funding - Bristol-Myers Squibb
 
Elena Pentsova
No Relationships to Disclose
 
Alex Miller
No Relationships to Disclose
 
Adam Newton
No Relationships to Disclose
 
Ashley Gonzalez
No Relationships to Disclose
 
Ingo K. Mellinghoff
Consulting or Advisory Role - Agios; Black Diamond Therapeutics; Debiopharm Group; Novartis; Prelude Therapeutics; Roche; SERVIER; Voyager Therapeutics
Research Funding - General Electric; Puma Biotechnology
 
Thomas Joseph Kaley
No Relationships to Disclose